Feb 19, 2018
60 Views
0 0

Life sciences startup Avro aims to deliver drugs to children and the elderly through skin patches

Written by

Avro, a life sciences startup in Y Combinator’s current batch, is banking on a method to deliver medications to populations unable to swallow or chew — it will administer them through the skin. Starting with allergy medications, the startup is developing skin patches that release drugs commonly used in seasonal allergies for children. The patches can deliver a variety of drugs. Read More

Avro, a life sciences startup in Y Combinator’s current batch, is banking on a method to deliver medications to populations unable to swallow or chew — it will administer them through the skin. Starting with allergy medications, the startup is developing skin patches that release drugs commonly used in seasonal allergies for children. The patches can deliver a variety of drugs. Read More

Article Categories:
Tech News

Leave a Reply

Your email address will not be published. Required fields are marked *